Caxton Corp as of Sept. 30, 2024
Portfolio Holdings for Caxton Corp
Caxton Corp holds 12 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | 60.3 | $15M | 5.1M | 2.85 | |
| Rezolute Com New (RZLT) | 26.5 | $6.4M | 1.3M | 4.85 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 6.8 | $1.6M | 2.9k | 573.74 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 2.2 | $530k | 1.2k | 460.10 | |
| Bicara Therapeutics (BCAX) | 1.2 | $279k | 11k | 25.47 | |
| Mind Medicine Mindmed Com New (MNMD) | 0.8 | $194k | 34k | 5.69 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $161k | 18k | 9.04 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.5 | $131k | 11k | 11.52 | |
| Kyverna Therapeutics (KYTX) | 0.5 | $112k | 23k | 4.89 | |
| Compass Therapeutics (CMPX) | 0.3 | $80k | 44k | 1.84 | |
| Context Therapeutics (CNTX) | 0.1 | $36k | 18k | 1.96 | |
| Adicet Bio (ACET) | 0.1 | $25k | 18k | 1.44 |
